New pill tested as potential alternative for leukemia treatment
Disease control
Completed
This study tested a new drug called IkT-001Pro to see if it works similarly in the body to the standard drug, imatinib, used to treat a type of blood cancer called CML. Researchers gave different doses of both drugs to healthy volunteers to compare safety and how the body absorbs…
Phase: PHASE1 • Sponsor: Inhibikase Therapeutics • Aim: Disease control
Last updated Mar 06, 2026 15:39 UTC